facebook twitter linkedin
news and events

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.



DISAGREE AGREE

Media about us

10.2015

Selvita in the BioWorld Today
BioWorld Today, Vol. 26, No. 183.

09.2015

Selvita moves in: The biggest Polish biotech on the Boston Block
Labiotech.eu

10.2014

Enter clinical stage from East
EuroBiotech News, Vol.14, 2014

09.2014

Awakening the sleeping giant
EuroBiotech News, Vol.13, 2014

08.2014

Selvita delivers excellet Q2 figures
PPN Weekly No 33 (483)

04.2014

Interview with Paweł Przewięźlikowski
PharmaBoardroom.com, 6 April 2014 

04.2014

Selvita to report 80% revenue rise for Q1
PPN Weekly No 14 (464)

01.2014 Selvita breaks into profit
PPN Weekly No 4 (454)
12.2013 Selvita keen to start phase 1 trials of first molecule in 2015 with help of partner
PPN Weekly No 51 (449)
11.2013 WilmerHale berät Selvita erneut bei Kollaborationsvertrag
WilmerHAle Pressemitteilung
11.2013

Selvita announces new executive board nominations
PPN Weekly No 45 (443)

10.2013

Selvita announces cancer research collaboration with Merck Serono
PPN Weekly No 44 (442)

10.2013

Merck Serono, Selvita to Collaborate on Cancer
Drug Discovery & Development, 24 October 2013

10.2013

Interview with Pawel Przewiezlikowski: Selvita plans more strategic partnerships with foreign pharma companies
CEPN No 20 (105), 3 October 2013, page 20

09.2013

Bioinformatics-driven Eisai subsidiary inks discovery alliance
News in FierceBiotechIT, 22 September 2013

H3 Biomedicine and Selvita Announce Strategic Collaboration to Develop Precision Cancer Medicines
News in FierceBiotechIT, 23 September 2013

01.2013

Selvita featured in Drug Discovery Today
Vol. 17, No. 23-24, December 2012

11.2012

Selvita in European Biotechnology News
No 6, Volume 11, 2012 

07.2012 Selvita in Poland Pharma News
PPN Issue No. 27 (373)
05.2012 Selvita in Poland Pharma News
PPN Issue No. 19 (365)
04.2012

Selvita in Poland Pharma News
PPN Issue No. 16 (362)

08.2011 Selvita in European Biotechnology News
No 5-6, Volume 10, 2011
07.2011 Selvita in Genetic Engeneering and Biotechnology News
July 2011
05.2011 Selvita featured in Biotech Finance
Biotech Finance, no 507, 16 May 2011
03.2011 Selvita in Poland Pharma News
PPN Issue No. 12 (306)
03.2011 Selvita in Mergermarkets
23 March 2011
12.2010 Selvita in Fierce Biotech
Selvita Appoints Piotr Prelich as a Vice President of Sales and Marketing
Fierce Biotech News
10.2010 Selvita in European Biotechnology News
No. 9-10, Volume 9, 2010
07.2010 Selvita in Poland Pharma News
PPN Issue No. 30 (272)
07.2010 An interview with Pawel Przewiezlikowski, Selvita's CEO
PPN Issue No. 30 (272)
07.2010 Selvita in Scripintelligence
07.2010 Selvita featured in Biotech Finance
Biotech Finance, no 471, 19 July 2010
06.2009 Selvita featured in Life Science Clusters
Life Science Clusters, BIO International Convention edt.
01.2009 Selvita in Nature Biotechnology
Volume 27, Number 1, January 2009
15.05.2008 Selvita Expands
European Biotechnology
10.04.2008 Selvita invests in BioCentrum and forms an alliance with Read-Gene
BIOPHARMACEUTIQUES
23.08.2007 Selvita - new biotechnology firm in Poland
PMR Business